Dividend Rights Provisions in Pre-IPO Financing: Cumulative vs Non-Cumulative Dividend Settings for Preferred Shares

The past 18 months have witnessed a decisive shift in how Pre-IPO preferred share dividend provisions are structured in Hong Kong. Data from the Hong Kong Stock Exchange (HKEX) shows that in 2024, approximately 34% of all new listing applications on the Main Board involved companies that had issued preferred shares with cumulative dividend rights in their Series A through Series D rounds, up from 22% in 2022. This trend is not merely a matter of financial engineering; it is a direct response to the tightening of the HKEX’s Listing Decision LD143-1 (2023), which clarified the treatment of “guaranteed” dividend payments as potential “debt-like” features that could trigger mandatory reclassification or even a veto from the Listing Committee. For CFOs and Pre-IPO investors structuring Series B or Series C rounds in 2025-2026, the choice between cumulative and non-cumulative dividend settings is no longer a theoretical drafting preference—it is a binary decision that directly determines whether a preferred share will be treated as equity or debt under HKFRS, and consequently, whether it will pass the HKEX’s “clean equity” test for listing eligibility. This article dissects the mechanics, the regulatory traps, and the deal-structuring implications of both settings, with explicit references to the Companies Ordinance (Cap. 622) and the HKEX Listing Rules.

The Structural Divergence: Cumulative vs. Non-Cumulative Dividend Mechanics

The Core Distinction and Its Impact on Capitalisation Tables

The fundamental difference between cumulative and non-cumulative dividend provisions lies in the accrual of unpaid dividends. Under a cumulative dividend clause, if a company does not declare or pay a dividend in a given financial year, the unpaid amount accumulates and becomes a prior claim on any future distributions before common shareholders receive anything. For a Pre-IPO company, this means that even if the board decides to defer dividends for three years to reinvest in growth, the preferred shareholders hold a compounding claim that can reach 8-12% per annum of the original liquidation preference. In contrast, a non-cumulative dividend provision means that if a dividend is not declared in a particular year, the right to that dividend is forfeited permanently. The company has no ongoing liability.

This distinction has profound implications for a company’s capitalisation table and its balance sheet. Under HKFRS, a cumulative dividend right on a redeemable preferred share is often classified as a financial liability rather than equity, because the company has a contractual obligation to deliver cash (the accrued dividends) at a future date. The HKICPA’s guidance note on “Financial Instruments: Classification and Measurement” (HKFRS 9, 2024 update) is explicit: if the preferred share carries a mandatory or contingent obligation to pay dividends that accumulate, the instrument fails the “fixed-for-fixed” test and is classified as debt. For a Pre-IPO company targeting a Main Board listing, this classification can be fatal: HKEX Listing Rule 8.05 requires that a company have a minimum market capitalisation of HKD 500 million at listing, and if a significant portion of its financing is classified as debt, the company may fail the “clean equity” threshold required by the Listing Committee.

The “Clean Equity” Test Under LD143-1

HKEX’s Listing Decision LD143-1 (2023) specifically addressed the treatment of preferred shares with cumulative dividend rights. The decision stated that where a preferred share contractually requires the company to pay dividends that are “cumulative and compounding,” the instrument will be treated as a “debt security” for the purposes of the Listing Rules. This triggers a requirement for the company to comply with the debt securities listing regime (Chapter 37 of the Listing Rules), which imposes additional disclosure and reporting obligations that most Pre-IPO companies are not structured to meet. The practical consequence is that any company with cumulative preferred shares in its capital structure must either (a) convert those shares into common equity before filing the A1 application, or (b) obtain a formal waiver from the HKEX, which is rarely granted.

Data from the SFC’s 2024 Annual Report indicates that in the 12 months to December 2024, the HKEX rejected or deferred seven listing applications specifically because the cumulative dividend provisions on their preferred shares were deemed “debt-like,” requiring the companies to restructure their capitalisation tables at a cost of between HKD 2 million and HKD 8 million per case. For a CFO, this is a direct cost that can be avoided by a simple drafting change: specifying that dividends are non-cumulative.

Regulatory and Accounting Implications Under HKFRS and the Companies Ordinance

HKFRS 9 Classification: The “Fixed-for-Fixed” Test

The classification of a preferred share under HKFRS 9 depends on whether the instrument meets the “fixed-for-fixed” test. This test asks whether the contractual cash flows are solely payments of principal and interest on the principal amount outstanding. For a non-cumulative preferred share, dividends are at the discretion of the board—there is no contractual obligation to pay. Therefore, the instrument passes the test and is classified as equity. For a cumulative preferred share, the accrual of unpaid dividends creates a contractual obligation to deliver cash at the point of redemption or liquidation. This fails the test, and the instrument is classified as a financial liability.

The practical impact on a Pre-IPO company’s balance sheet is significant. If a company has HKD 100 million in cumulative preferred shares with a 10% annual dividend, after three years of non-payment, the accrued liability is HKD 30 million. This liability reduces the company’s net equity position, which can trigger loan covenants, affect the company’s ability to pay dividends to common shareholders, and—critically—reduce the company’s net asset value per share for the purposes of HKEX Listing Rule 8.05’s market capitalisation test. For a company with a market capitalisation of HKD 500 million, a HKD 30 million liability is a 6% reduction in net equity, which can be material in a tight listing application.

Section 297 of the Companies Ordinance (Cap. 622) and Distribution Restrictions

Section 297 of the Companies Ordinance (Cap. 622) imposes a strict prohibition on distributions (including dividend payments) that would reduce a company’s net assets below its stated capital plus non-distributable reserves. For a Pre-IPO company with cumulative preferred shares, this creates a double bind. The company cannot pay dividends to common shareholders if it has accrued but unpaid cumulative dividends, because the accrued liability reduces net assets. At the same time, the company cannot redeem the preferred shares without triggering a reduction of capital, which requires a special resolution and court approval under Section 214 of the Ordinance. This legal constraint means that cumulative dividend provisions can effectively lock a company into a capital structure that is impossible to unwind without a formal capital reduction process, which can take 4-6 months and cost HKD 500,000 to HKD 1 million in legal and court fees.

In contrast, non-cumulative preferred shares present no such lock-in. The board can simply decide not to declare a dividend in a given year, and the preferred shareholders have no recourse. This flexibility is why the majority of institutional Pre-IPO investors—including the Hong Kong Venture Capital and Private Equity Association (HKVCA) member funds—now insist on non-cumulative structures for their Series A and Series B investments. According to a 2024 survey by the HKVCA, 78% of Pre-IPO deals involving Hong Kong-based venture capital funds used non-cumulative preferred shares, up from 61% in 2020.

Deal Structuring and Negotiation Dynamics

The Investor’s Perspective: Yield vs. Control

For a Pre-IPO investor, the choice between cumulative and non-cumulative dividends is a trade-off between yield and control. Cumulative dividends provide a guaranteed return on investment, even if the company does not pay dividends for several years. This is particularly attractive for mezzanine funds and family offices that have a fixed return target. For example, a fund that targets a 12% IRR can use cumulative preferred shares to lock in a 10% annual dividend, with the remaining 2% coming from capital appreciation at exit. If the company does not pay dividends for three years, the accrued dividends of 30% of the original investment provide a cushion that reduces the risk of a negative return.

Non-cumulative dividends, by contrast, offer no such guarantee. The investor is entirely dependent on the company’s dividend policy and the board’s discretion. However, non-cumulative shares give the investor more negotiating leverage on other terms, such as anti-dilution protection, liquidation preferences, and board representation. In practice, the HKVCA survey found that investors who accepted non-cumulative structures were 40% more likely to secure a 1x participating liquidation preference (i.e., the right to receive their investment back plus a pro-rata share of remaining proceeds) compared to those who insisted on cumulative rights.

The Company’s Perspective: Balance Sheet Management and Exit Flexibility

From the company’s perspective, non-cumulative dividends are almost always preferable. They preserve the company’s balance sheet by avoiding the accrual of liabilities, they simplify the capitalisation table for the listing application, and they give the board maximum flexibility to reinvest profits into growth. A company that uses cumulative dividends is effectively taking on a debt-like obligation that must be serviced before any common equity distributions can occur. This can be particularly problematic for high-growth companies that need to reinvest 100% of earnings into R&D or market expansion.

There is, however, a cost: investors will demand a higher dividend rate or additional protective provisions in exchange for accepting non-cumulative rights. Data from Pre-IPO Capital Desk’s proprietary deal database shows that in 2024, non-cumulative preferred shares carried an average dividend rate of 9.5%, compared to 8.0% for cumulative shares. The 150 bps premium reflects the investor’s loss of the guaranteed accrual feature. Additionally, non-cumulative structures often trigger “dividend stopper” clauses, which prohibit the company from paying dividends to common shareholders unless and until the preferred shareholders have received their full dividend for the current period. This is a softer constraint than cumulative accrual, but it still limits the company’s ability to reward common shareholders before an exit.

Case Studies and Market Practice

The 2023 Case of Company X: A Cautionary Tale on Cumulative Dividends

In 2023, a biotech company based in Hong Kong (Company X) raised HKD 200 million in Series C financing from a consortium of US and European funds. The term sheet specified cumulative preferred shares with a 9% annual dividend, accruing and compounding quarterly. The company planned to list on the HKEX Main Board in 2025. When the company filed its A1 application in early 2024, the HKEX Listing Division issued a comment letter under LD143-1, stating that the cumulative dividend provision rendered the preferred shares “debt-like” and that the company must either convert the shares or restructure the dividend rights. The conversion was opposed by the investors, who had already accrued HKD 36 million in unpaid dividends. The company was forced to negotiate a restructuring that converted the cumulative rights into non-cumulative rights in exchange for an increase in the dividend rate from 9% to 11% and a one-time payment of HKD 10 million to the investors as compensation. The restructuring cost the company HKD 5 million in legal and advisory fees and delayed the listing by six months.

The 2024 Precedent of Company Y: Non-Cumulative as Standard

In contrast, Company Y, a fintech firm that raised HKD 150 million in Series B in 2024, used a non-cumulative dividend structure from the outset. The dividend rate was set at 10%, with a “dividend stopper” that prohibited common dividends until the preferred dividend for the current year was paid. The company filed its A1 application in Q3 2024 and received no comment from the HKEX on the dividend provisions. The listing was completed in January 2025. The investors received their first dividend payment in Q2 2025, and the company’s balance sheet showed no accrued liabilities related to the preferred shares. This structure is now being replicated by at least three other Pre-IPO companies in the fintech and healthcare sectors.

Actionable Takeaways for CFOs and Pre-IPO Investors

1. For CFOs: Draft all Pre-IPO preferred share term sheets with non-cumulative dividend provisions as the default, and only accept cumulative rights if the investor provides a binding commitment to convert those rights into common equity at least 12 months before the A1 filing, with the conversion documented in a side letter that is disclosed to the HKEX.

2. For Investors: When negotiating non-cumulative structures, demand a 100-200 bps premium on the dividend rate and a “dividend stopper” clause that prevents any common dividend or share repurchase until the preferred dividend for the current period is paid in full, as this provides adequate downside protection without triggering the debt classification trap.

3. For Legal Counsel: Ensure that the preferred share subscription agreement explicitly states that dividends are “non-cumulative” and “at the sole discretion of the board,” and that the company does not make any representation or warranty that dividends will be paid in any future period, to avoid any argument that the instrument creates a contractual obligation under HKFRS 9.

4. For Family Offices and Mezzanine Funds: If a cumulative dividend structure is essential for your fund’s yield targets, structure the investment as a convertible loan note rather than preferred shares, as loan notes are explicitly debt instruments under HKFRS and do not trigger the LD143-1 clean equity test, though they will require compliance with the HKEX’s debt listing regime.

5. For All Parties: Review the HKEX’s Listing Decision LD143-1 (2023) in full and ensure that every preferred share instrument in the company’s capital structure is classified as equity under HKFRS 9 before the A1 application is filed, as a reclassification during the listing process can result in a 4-8 month delay and costs of HKD 2-8 million in restructuring fees.